Cargando…
Targeting arachidonic acid–related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles
In March 2020, The World Health Organization (WHO) has declared that the coronavirus disease 2019 (COVID-19) is characterized as a global pandemic. As of September 2020, infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to 213 countries and territories around...
Autores principales: | Shoieb, Sherif M., El-Ghiaty, Mahmoud A., El-Kadi, Ayman O. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670111/ https://www.ncbi.nlm.nih.gov/pubmed/33225219 http://dx.doi.org/10.1007/s42247-020-00136-8 |
Ejemplares similares
-
Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms
por: El-Ghiaty, Mahmoud A., et al.
Publicado: (2020) -
Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites
por: Shoieb, Sherif M., et al.
Publicado: (2020) -
Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target
por: Elshenawy, Osama H., et al.
Publicado: (2017) -
Arsenic: Various species with different effects on cytochrome P450 regulation in humans
por: El-Ghiaty, Mahmoud A., et al.
Publicado: (2021) -
Methylmercury (MeHg) transcriptionally regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) in Hepa-1c1c7 cells
por: Alqahtani, Mohammed A., et al.
Publicado: (2023)